Court tosses long-running suit against Finra

A federal appeals court last Tuesday agreed that a lawsuit brought by a brokerage firm over the 2007 merger of NASD and the regulatory arm of the New York Stock Exchange should be thrown out
FEB 27, 2011
A federal appeals court last Tuesday agreed that a lawsuit brought by a brokerage firm over the 2007 merger of NASD and the regulatory arm of the New York Stock Exchange should be thrown out. That union created the Financial Industry Regulatory Authority Inc., the self-regulatory organization for broker-dealers. The 2nd U.S. Circuit Court of Appeals affirmed a lower court's decision that dismissed a class action filed by Standard Investment Chartered Inc. against NASD, Finra and its executives. The suit's targets included then-NASD chief Mary Schapiro, who is now chairman of the Securities and Exchange Commission. The lawsuit alleged that Finra executives misled brokerage firm members by claiming that $35,000 was the most that could be paid to member firms upon completion of the merger. U.S. District Court Judge Jed Rakoff originally ruled that the defendants had “absolute immunity” from lawsuits. The three-judge appeals panel agreed. “There is no question that an SRO and its officers are entitled to absolute immunity from private damages suits in connection with the discharge of their regulatory responsibilities,” the judges wrote in upholding Mr. Rakoff's ruling. A Finra spokesman said that the organization is “pleased with the decision.” The case against NASD was filed in May 2007. A similar case was filed by Benchmark Financial Services Inc. in December 2008. The Benchmark case is still pending in federal court, according to Jonathan Cuneo, an attorney representing Standard Investment and Benchmark. He said that he is studying the appeals court's decision. E-mail Liz Skinner at [email protected].

Latest News

GLP-1 users are trading retirement savings for their prescriptions
GLP-1 users are trading retirement savings for their prescriptions

A Nationwide survey finds 47% of GLP-1 users have never discussed the drugs’ financial impact with an advisor, even as many dip into savings.

Inspired Healthcare sale price of properties is 59% of $1.2 billion sold by advisors
Inspired Healthcare sale price of properties is 59% of $1.2 billion sold by advisors

The hundreds of millions of dollars from a sale of Inspired Healthcare properties does not mean an immediate windfall for investors.

Class action alleges Webull misled investors about China operations
Class action alleges Webull misled investors about China operations

Its SEC filings said one thing - a congressional probe said another.

Investors accuse Netcapital of inflating revenue through sham deals
Investors accuse Netcapital of inflating revenue through sham deals

Sham agreements allegedly padded revenue by 345%.

Pre-retirees are looking for flexibility, security, and guidance when it comes to retirement income: Cerulli
Pre-retirees are looking for flexibility, security, and guidance when it comes to retirement income: Cerulli

"Most pre-retirees are uncomfortable making key retirement income decisions without an advisor's help," said Chris Bailey of Cerulli.

SPONSORED Built on insurance experience to deliver on long-term promises

Knighthead Life entered the market with a competitive MYGA. A strong launch earned advisor confidence and paved the way for FIAs.

SPONSORED In the Age of AI, Trust Becomes the Advisor's Greatest Asset

As AI makes financial information more accessible than ever, Lana Hock explains why human judgment, trust, and empathy remain the qualities clients value most in a financial advisor